Individuals with adult‐onset T1D typically exhibit a lower genetically determined risk and show a progressive loss of multiple diabetes‐associated autoantibodies over time, with glutamic acid decarboxylase (GAD) antibodies being the most persistent. This evidence concerns the gene GAD1 and diabetes mellitus.